Delay in diagnosis of chronic obstructive pulmonary disease: Reasons and solutions

Current Opinion in Pulmonary Medicine

Volumn 21, Issue 2, 2015, Pages 121-126

  Jagana, Rajani ^a   Bartter, Thaddeus ^a,b   Joshi, Manish ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

chronic obstructive pulmonary disease; cigarette smoking; spirometry

Indexed keywords

ASTHMA; AWARENESS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIAGNOSTIC ERROR; HEALTH CARE PERSONNEL; HUMAN; PATIENT EDUCATION; REVIEW; RISK FACTOR; SMOKING; SYMPTOMATOLOGY; EARLY DIAGNOSIS; PATHOPHYSIOLOGY; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPIROMETRY; SYNDROME;

EARLY DIAGNOSIS; HUMANS; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPIROMETRY; SYNDROME;

EID: 84922401150     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0000000000000133     Document Type: Review

References (40)

1. World Health Organization. Chronic obstructive pulmonary disease (COPD). http://www.who.int/respiratory/copd/burDen/en/. [Accessed 8 September 2014]
2. Diaz-Guzman E, Mannino DM. EpiDemiology and prevalence of chronic obstructive pulmonary disease. Clin Chest Med 2014; 35:7-16
3. Rycroft CE, Heyes A, Lanza L, Becker K. EpiDemiology of chronic obstructive pulmonary disease: a literature review. Int J Chron Obstruct Pulmon Dis 2012; 7:457-494
4. Song Y, Zhao L, Palipudi KM, et al. Global Adult Tobacco Survey (GATS) Collaborative Group Tracking MPOWER in 14 countries: results from the Global Adult Tobacco Survey, 2008-2010. Glob Health Promot 2013. [Epub ahead of print]
5. Joshi M, Joshi A, Bartter T. Symptom burDen in chronic obstructive pulmonary disease and cancer. Curr Opin Pulm Med 2012; 18:97-103
6. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23:932-946
7. Vestbo J, Hurd SS, Agust AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187:347-365
8. Pellegrino R, Viegi G, Brusasco V. Interpretative strategies for lung function tests. Eur Respir J 2005; 26:948-968
9. Jones RCM, Price D, Ryan D, et al. Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort. Lancet Respir Med 2014; 2:267-276
10. Yawn BP, Wollan PC. Knowledge and attituDes of family physicians coming to COPD continuing medical education. Int J Chron Obstruct Pulmon Dis 2008; 3:311-317
11. Han MK, Kim MG, Mardon R, et al. Spirometry utilization for COPD: how do we measure up? Chest 2007; 132:403-409
12. Joo MJ, Lee TA, Weiss KB. Geographic variation of spirometry use in newly diagnosed COPD. Chest 2008; 134:38-45
13. Soriano JB, Zielinski J, Price D. Screening for and early Detection of chronic obstructive pulmonary disease. Lancet 2009; 374:721-732
14. Miravitlles M, De La Roza C, Morera J, et al. Chronic respiratory symptoms, spirometry and knowledge of COPD among general population. Respir Med 2006; 100:1973-1980
15. Halding AG, Heggdal K, Wahl A. Experiences of self-blame and stigmatisation for self-infliction among individuals living with COPD. Scand J Caring Sci 2011; 25:100-107
16. Omachi TA, Sarkar U, Yelin EH, et al. Lower health literacy is associated with poorer health status and outcomes in chronic obstructive pulmonary disease. J Gen Intern Med 2013; 28:74-81
17. Van Den Boom G, Rutten-Van Molken MP, Tirimanna PR, et al. Association between health-related quality of life and consultation for respiratory symptoms: results from the DIMCA programme. Eur Respir J 1998; 11:67-72
18. Zeng G, Sun B, Zhong N. Nonsmoking-related chronic obstructive pulmonary disease: a neglected entity? Respirology 2012; 17:908-912
19. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in nonsmokers. Lancet 2009; 374:733-743
20. Pleasants RA, Ohar JA, Croft JB, et al. Chronic obstructive pulmonary disease and asthma-patient characteristics and health impairment. COPD 2014; 11:256-266
21. Tinkelman DG, Price DB, Nordyke RJ, Halbert RJ. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over. J Asthma 2006; 43:75-80
22. Chung JW, Kong Ka, Lee JH, et al. Characteristics and self-rated health of overlap syndrome. Int J Chron Obstruct Pulmon Dis 2014; 9:795-804
23. Chapman KR, Tashkin DP, Pye DJ. GenDer bias in the diagnosis of COPD. Chest 2001; 119:1691-1695
24. Menezes AM, Montes De Oca M, Perez-Padilla R, et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-Asthma. Chest 2014; 145:297-304
25. Miravitlles M, Soriano JB, Ancochea J, et al. Characterisation of the overlap COPD-Asthma phenotype. Focus on physical activity and health status. Respir Med 2013; 107:1053-1060
26. Carolan BJ, Sutherland ER. Clinical phenotypes of chronic obstructive pulmonary disease and asthma: recent adVances. J Allergy Clin Immunol 2013; 131:627-634
27. Agusti A, Calverley PMA, Celli B, et al. Evaluation of COPD Longitudinally to IDentify Predictive Surrogate Endpoints (ECLIPSE) investigators. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010; 11:122
28. Vestbo J, Agusti A, Wouters EFM, et al. Should we view chronic obstructive pulmonary disease differently after ECLIPSE. Am J Respir Crit Care Med 2014; 189:1022-1030
29. Miller J, Edwards LD, Agusti A, et al. Evaluation of COPD Longitudinally to IDentify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respir Med 2013; 107:1376-1384
30. Qaseem A, Wilt TJ, Weinberger SE. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guiDeline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med 2011; 155:179-191
31. Guarascio AJ, Ray SM, Finch CK, Self TH. The clinical and economic burDen of chronic obstructive pulmonary disease in the USA. Clinicoecon Outcomes Res 2013; 5:235-245
32. Zielinski J, Bednarek M. Know the Age of Your Lung Study Group. Early Detection of COPD in a high-risk population using spirometric screening. Chest 2001; 119:731-736
33. King BA, Mirza SA, Babb SD; GATS Collaborating Group. A cross country comparison of secondhand smoke exposure among adults: findings from the Global Adult Tobacco Survey (GATS). Tob Control 2013; 22:e5
34. Jetter J, Zhao Y, Smith KR, et al. Pollutant emissions and energy efficiency unDer controlled conditions for household biomass cookstoves and implications for metrics useful in setting international test standards. Environ Sci Technol 2012; 46:10827-10834
35. Balakrishnan K, Ghosh S, Ganguli B, et al. State and national household concentrations of PM2.5 from solid cookfuel use: results from measurements and moDelling in India for estimation of the global burDen of disease. Environ Health 2013; 12:77
36. Gordon SB, Bruce NG, Grigg J, et al. Respiratory risks from household air pollution in low and middle income countries. Lancet Respir Med 2014; 2:823-860
37. Schermer TR, Smeele IJ, Thoonen BP, et al. Current clinical guiDeline Definitions of airflow obstruction and COPD overdiagnosis in primary care. Eur Respir J 2008; 32:945-952
38. Choudhury G, Rabinovich R, MacNee W. Comorbidities and systemic effects of chronic obstructive pulmonary disease. Clin Chest Med 2014; 35:101-130
39. Chilvers ER, Lomas DA. Diagnosing COPD in nonsmokers: splitting not lumping. Thorax 2010; 65:465-466
40. The 1964 Report on Smoking and Health. [online report] http://profiles. nlm.nih.gov/ps/retrieve/Narrative/NN/p-nid/60. [Accessed 1 October 2014]